Friendlier regulatory environment expected
Previously warned on pharma dividends
Housebuilders and retailers
A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.
Central bank action has reduced volatility